The CD8 + effector T cell response induced by anti-PD-1 may therefore in part rely on the influx of new CD8 + T cell clones issued from the periphery, in line with preclinical models showing impaired response to anti-PD-1 when interfering with the migration of immune cells into the tumor [129]. The gene discussed is PDCD1; the disease is neoplasm.